Clinical Trials

Showing trials with last updates posted in 2020.

NCT00939770 | COMPLETED | PHASE1/PHASE2
122 participants

Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2020-06-09
Start Date:
2009-09-21
Completion:
2018-12-31
Conditions
  • Recurrent Childhood Anaplastic Large Cell Lymphoma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Neuroblastoma
  • Refractory Anaplastic Large Cell Lymphoma
  • Refractory Malignant Solid Neoplasm
  • Refractory Neuroblastoma
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page